Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Obesity and lifestyle strongly affect heart aging.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Model improves accuracy in predicting hair loss effects.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

AR gene variations don't affect aging markers in men.

H. pylori infection may be linked to insulin resistance in women with PCOS.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Flavonoids in Iraqi marshland plants have potential health benefits like antioxidant and anti-inflammatory effects.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Hair loss linked to higher heart disease risk in both men and women.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.